Skip to main content

Defiance Nasdaq Junior Biotechnology ETF

Open-end / ETF
Registrant
ETF Series Solutions
Net Assets
$7,248,014
Holdings
232
Latest Report
Sep 30, 2021

Net Assets Over Time

Holdings · 232

Export CSV
Showing 1–50 of 232 holdings by value · page 1 of 5
Holding Balance Value % of Fund Open
Allakos Inc
1,235 $130,749 1.80%
Arena Pharmaceuticals Inc
1,400 $83,370 1.15%
Karuna Therapeutics Inc
675 $82,573 1.14%
Nektar Therapeutics
4,205 $75,522 1.04%
Turning Point Therapeutics Inc
1,125 $74,734 1.03%
Reata Pharmaceuticals Inc
720 $72,439 1.00%
SpringWorks Therapeutics Inc
1,130 $71,687 0.99%
Intra-Cellular Therapies Inc
1,860 $69,341 0.96%
Apellis Pharmaceuticals Inc
1,990 $65,590 0.90%
Cortexyme Inc
680 $62,329 0.86%
Sage Therapeutics Inc
1,345 $59,597 0.82%
Amicus Therapeutics Inc
6,100 $58,255 0.80%
NanoString Technologies Inc
1,040 $49,930 0.69%
Revance Therapeutics Inc
1,645 $45,830 0.63%
Amarin Corp PLC
8,925 $45,518 0.63%

Showing the top 50 of 232 holdings. Create a free account to see every holding and download the CSV.